Interpharm Holdings, Inc. (IPAH)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 10, 2025
Interpharm Holdings Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | 2000 - 2002 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '07 Dec 31, 2007 | Jun '07 Jun 30, 2007 | Jun '06 Jun 30, 2006 | Jun '05 Jun 30, 2005 | Jun '04 Jun 30, 2004 | Jun '03 Jun 30, 2003 | 2000 - 2002 |
| 69.21 | 75.59 | 63.36 | 39.91 | 41.1 | 27.52 | Upgrade | |
Revenue Growth (YoY) | -5.06% | 19.31% | 58.74% | -2.89% | 49.33% | 13.20% | Upgrade |
Cost of Revenue | 57.21 | 53.92 | 45.93 | 30.84 | 31.38 | 22.54 | Upgrade |
Gross Profit | 12 | 21.67 | 17.43 | 9.07 | 9.72 | 4.99 | Upgrade |
Selling, General & Admin | 14.75 | 13.44 | 11.52 | 5.16 | 4.12 | 2.52 | Upgrade |
Research & Development | 17.03 | 18.96 | 10.67 | 4 | 0.54 | 0.45 | Upgrade |
Operating Expenses | 31.78 | 32.41 | 22.2 | 9.17 | 4.66 | 2.97 | Upgrade |
Operating Income | -19.78 | -10.74 | -4.77 | -0.1 | 5.06 | 2.01 | Upgrade |
Interest Expense | -2.48 | -1.28 | -0.72 | -0.14 | -0.02 | -0.28 | Upgrade |
Interest & Investment Income | - | - | - | - | 0.07 | 0.01 | Upgrade |
EBT Excluding Unusual Items | -22.14 | -12.01 | -5.49 | -0.23 | 5.11 | 1.74 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 0.01 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.1 | -0.1 | -0.01 | - | - | - | Upgrade |
Asset Writedown | -0.1 | -0.1 | - | - | - | - | Upgrade |
Other Unusual Items | - | -1.66 | - | - | - | - | Upgrade |
Pretax Income | -22.27 | -13.87 | -5.49 | -0.22 | 5.11 | 1.74 | Upgrade |
Income Tax Expense | 7.09 | 0.19 | -1.7 | -0.07 | 1.99 | 0.58 | Upgrade |
Net Income | -29.36 | -14.06 | -3.79 | -0.15 | 3.12 | 1.16 | Upgrade |
Preferred Dividends & Other Adjustments | 4.34 | 2.75 | 1.73 | 0.17 | 0.36 | 0.15 | Upgrade |
Net Income to Common | -33.69 | -16.8 | -5.52 | -0.32 | 2.76 | 1.01 | Upgrade |
Net Income Growth | - | - | - | - | 168.47% | 10.74% | Upgrade |
Shares Outstanding (Basic) | 66 | 65 | 37 | 26 | 18 | 7 | Upgrade |
Shares Outstanding (Diluted) | 66 | 65 | 37 | 26 | 69 | 39 | Upgrade |
Shares Change (YoY) | 25.21% | 78.64% | 42.19% | -62.58% | 76.90% | 7.97% | Upgrade |
EPS (Basic) | -0.51 | -0.26 | -0.15 | -0.01 | 0.16 | 0.15 | Upgrade |
EPS (Diluted) | -0.51 | -0.26 | -0.15 | -0.01 | 0.04 | 0.03 | Upgrade |
EPS Growth | - | - | - | - | 34.94% | 1.41% | Upgrade |
Free Cash Flow | -29.61 | -22.11 | -6.03 | -10.47 | -2.3 | -0.27 | Upgrade |
Free Cash Flow Per Share | -0.45 | -0.34 | -0.17 | -0.41 | -0.03 | -0.01 | Upgrade |
Gross Margin | 17.34% | 28.67% | 27.51% | 22.73% | 23.66% | 18.12% | Upgrade |
Operating Margin | -28.58% | -14.21% | -7.52% | -0.24% | 12.31% | 7.31% | Upgrade |
Profit Margin | -48.68% | -22.23% | -8.71% | -0.79% | 6.72% | 3.69% | Upgrade |
Free Cash Flow Margin | -42.78% | -29.25% | -9.52% | -26.22% | -5.59% | -0.98% | Upgrade |
EBITDA | -16.57 | -8.32 | -3.23 | 1.15 | 5.95 | 2.6 | Upgrade |
EBITDA Margin | -23.94% | -11.00% | -5.10% | 2.89% | 14.47% | 9.46% | Upgrade |
D&A For EBITDA | 3.21 | 2.42 | 1.53 | 1.25 | 0.89 | 0.59 | Upgrade |
EBIT | -19.78 | -10.74 | -4.77 | -0.1 | 5.06 | 2.01 | Upgrade |
EBIT Margin | -28.58% | -14.21% | -7.52% | -0.24% | 12.31% | 7.31% | Upgrade |
Effective Tax Rate | - | - | - | - | 38.87% | 33.29% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.